Deutsche Bank lowered the firm’s price target on Humana to $250 from $349 and keeps a Hold rating on the shares. For 2025, only 25% of Humana’s members are currently covered by bonus-qualified plans for 2025, down from 94% in 2024, the analyst tells investors in a research note. The firm says the preliminary star results “clearly missed investors’ expectations and strike as a significant risk concern” on the company’s 2026 financial performance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
Questions or Comments about the article? Write to editor@tipranks.com